Ligand Pharmaceuticals, Inc. (LGND)
284.10
+3.61
(+1.29%)
USD |
NASDAQ |
Aug 31, 16:00
282.20
-1.90
(-0.67%)
After-Hours: 07:17
Ligand Pharmaceuticals Total Long Term Debt (Quarterly) : 1.130B for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.130B |
| March 31, 2026 | 450.89M |
| December 31, 2025 | 450.40M |
| September 30, 2025 | 449.91M |
| June 30, 2025 | 4.653M |
| March 31, 2025 | 3.589M |
| December 31, 2024 | 5.839M |
| September 30, 2024 | 6.291M |
| June 30, 2024 | 6.427M |
| March 31, 2024 | 5.194M |
| December 31, 2023 | 5.762M |
| September 30, 2023 | 5.832M |
| June 30, 2023 | 10.99M |
| March 31, 2023 | 88.02M |
| December 31, 2022 | 87.08M |
| September 30, 2022 | 111.54M |
| June 30, 2022 | 142.11M |
| March 31, 2022 | 193.35M |
| December 31, 2021 | 323.02M |
| September 30, 2021 | 328.40M |
| June 30, 2021 | 320.13M |
| March 31, 2021 | 363.83M |
| December 31, 2020 | 454.53M |
| September 30, 2020 | 458.89M |
| June 30, 2020 | 458.85M |
| Date | Value |
|---|---|
| March 31, 2020 | 453.66M |
| December 31, 2019 | 648.93M |
| September 30, 2019 | 641.46M |
| June 30, 2019 | 661.78M |
| March 31, 2019 | 648.06M |
| December 31, 2018 | 636.30M |
| September 30, 2018 | 815.98M |
| June 30, 2018 | 806.28M |
| March 31, 2018 | 243.62M |
| December 31, 2017 | 262.25M |
| September 30, 2017 | 243.15M |
| June 30, 2017 | 242.92M |
| March 31, 2017 | 242.70M |
| December 31, 2016 | 242.47M |
| September 30, 2016 | 242.25M |
| June 30, 2016 | 242.04M |
| March 31, 2016 | 204.65M |
| December 31, 2015 | 241.61M |
| September 30, 2015 | 202.95M |
| June 30, 2015 | 200.57M |
| March 31, 2015 | 198.57M |
| December 31, 2014 | 196.24M |
| September 30, 2014 | 193.97M |
| June 30, 2014 | 2.698M |
| March 31, 2014 | 5.769M |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Johnson & Johnson | 37.34B |
| Eli Lilly & Co. | 49.62B |
| Merck & Co., Inc. | 51.08B |
| Zevra Therapeutics, Inc. | 0.87M |
| Liquidia Corp. | 182.90M |